Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1979 1
1980 1
1981 3
1982 13
1983 28
1984 58
1985 52
1986 29
1987 34
1988 129
1989 220
1990 208
1991 200
1992 208
1993 207
1994 213
1995 230
1996 244
1997 185
1998 174
1999 211
2000 214
2001 222
2002 181
2003 193
2004 211
2005 219
2006 226
2007 268
2008 206
2009 196
2010 215
2011 231
2012 237
2013 241
2014 262
2015 283
2016 280
2017 289
2018 307
2019 316
2020 245
2021 43
Text availability
Article attribute
Article type
Publication date

Search Results

7,192 results
Results by year
Filters applied: . Clear all
Page 1
Adult T-Cell Leukemia/Lymphoma. Review of the Literature.
Rodríguez-Zúñiga MJM, Cortez-Franco F, Qujiano-Gomero E. Rodríguez-Zúñiga MJM, et al. Actas Dermosifiliogr. 2018 Jun;109(5):399-407. doi: 10.1016/j.ad.2017.08.014. Epub 2018 Apr 21. Actas Dermosifiliogr. 2018. PMID: 29685460 Free article. Review. English, Spanish.
Adult T-cell Leukemia/Lymphoma (ATLL) is an aggressive neoplasm of T lymphocytes associated with Human T-lymphotropic virus type1 (HTLV-1) infection. ...Treatment based on chemotherapy, antiretroviral, and allogenic stem cell
Adult T-cell Leukemia/Lymphoma (ATLL) is an aggressive neoplasm of T lymphocytes associated with H
Genetic alterations in adult T-cell leukemia/lymphoma.
Kogure Y, Kataoka K. Kogure Y, et al. Cancer Sci. 2017 Sep;108(9):1719-1725. doi: 10.1111/cas.13303. Epub 2017 Jul 29. Cancer Sci. 2017. PMID: 28627735 Free PMC article. Review.
Adult T-cell leukemia/lymphoma (ATL) is a peripheral T-cell neoplasm with a dismal prognosis. It is caused by human T-cell leukemia virus type-1 (HTLV-1) retrovirus. A long latency period from HTLV-1 infection
Adult T-cell leukemia/lymphoma (ATL) is a peripheral T-cell neoplasm with a dismal prognosi
Adult T Cell Leukemia-Lymphoma (ATL): State of the Art.
Phillips AA, Harewood JCK. Phillips AA, et al. Curr Hematol Malig Rep. 2018 Aug;13(4):300-307. doi: 10.1007/s11899-018-0458-6. Curr Hematol Malig Rep. 2018. PMID: 30047026 Review.
PURPOSE OF REVIEW: ATL is a rare and highly aggressive T cell malignancy caused by HTLV-1. We will review the state of the art of ATL epidemiology, pathogenesis, diagnosis, and treatment. ...Molecular studies have identified key alterations in T cell s …
PURPOSE OF REVIEW: ATL is a rare and highly aggressive T cell malignancy caused by HTLV-1. We will review the state of the art …
Adult T-Cell Leukemia-Lymphoma.
Munakata W, Tobinai K. Munakata W, et al. Cancer Treat Res. 2019;176:145-161. doi: 10.1007/978-3-319-99716-2_7. Cancer Treat Res. 2019. PMID: 30596217
Adult T-cell leukemia-lymphoma (ATL) is a peripheral T-lymphocyte malignancy caused by an RNA retrovirus, human T-cell leukemia virus type 1. ATL is clinically classified into four disease subtypes. The acute, lymp
Adult T-cell leukemia-lymphoma (ATL) is a peripheral T-lymphocyte malignancy caused by an RNA retr
Treatment advances and prognosis for patients with adult T-cell leukemia-lymphoma.
Katsuya H, Ishitsuka K. Katsuya H, et al. J Clin Exp Hematop. 2017 Dec 27;57(3):87-97. doi: 10.3960/jslrt.17008. Epub 2017 Jun 8. J Clin Exp Hematop. 2017. PMID: 28592744 Free PMC article. Review.
A classification for adult T-cell leukemia-lymphoma (ATL) based on clinical features was proposed in 1991: acute, lymphoma, chronic, and smoldering types, and their median survival times (MSTs) were reported to be 6.2, 10.2, 24.3 months, …
A classification for adult T-cell leukemia-lymphoma (ATL) based on clinical features was proposed in 1991 …
A Review of New Findings in Adult T-cell Leukemia-Lymphoma: A Focus on Current and Emerging Treatment Strategies.
Hermine O, Ramos JC, Tobinai K. Hermine O, et al. Adv Ther. 2018 Feb;35(2):135-152. doi: 10.1007/s12325-018-0658-4. Epub 2018 Feb 6. Adv Ther. 2018. PMID: 29411267 Free PMC article. Review.
Adult T-cell leukemia-lymphoma (ATL), a rare and aggressive T-cell malignancy caused by human T-cell lymphotropic virus type 1 (HTLV-1), is associated with a poor prognosis. ...
Adult T-cell leukemia-lymphoma (ATL), a rare and aggressive T-cell malignancy caused by hum
Adult T-cell leukemia/lymphoma.
Oliveira PD, Farre L, Bittencourt AL. Oliveira PD, et al. Rev Assoc Med Bras (1992). 2016 Oct;62(7):691-700. doi: 10.1590/1806-9282.62.07.691. Rev Assoc Med Bras (1992). 2016. PMID: 27925051 Free article. Review.
Adult T-cell leukemia/lymphoma (ATL) is a malignancy of mature CD4+ T-cells caused by human T-cell lymphotropic virus type 1 (HTLV-1). ...ATL affects about 5% of infected individuals and is classified in the following clinic
Adult T-cell leukemia/lymphoma (ATL) is a malignancy of mature CD4+ T-cells caused by human T
Adult T-cell leukemia/lymphoma.
Qayyum S, Choi JK. Qayyum S, et al. Arch Pathol Lab Med. 2014 Feb;138(2):282-6. doi: 10.5858/arpa.2012-0379-RS. Arch Pathol Lab Med. 2014. PMID: 24476526 Free article. Review.
Adult T-cell leukemia/lymphoma is a rare mature CD4(+) T-cell neoplasm caused by the retrovirus human T-lymphotrophic virus type 1. ...Adult T-cell leukemia/lymphoma has 4 subtypes: acute,
Adult T-cell leukemia/lymphoma is a rare mature CD4(+) T-cell neoplasm caused by the retrov
Adult T-cell Leukemia/Lymphoma: A Problem Abroad and at Home.
Dittus C, Sloan JM. Dittus C, et al. Hematol Oncol Clin North Am. 2017 Apr;31(2):255-272. doi: 10.1016/j.hoc.2016.11.005. Hematol Oncol Clin North Am. 2017. PMID: 28340877 Review.
Adult T-cell leukemia/lymphoma (ATLL) is a rare T-cell disorder that is etiologically linked to chronic infection with human T-cell lymphotropic virus type 1. ...
Adult T-cell leukemia/lymphoma (ATLL) is a rare T-cell disorder that is etiologically linke
[Adult T-cell leukemia-lymphoma: ATL].
Fukushima T. Fukushima T. Rinsho Ketsueki. 2019;60(3):247-248. doi: 10.11406/rinketsu.60.247. Rinsho Ketsueki. 2019. PMID: 31068533 Japanese. No abstract available.
7,192 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page